143 related articles for article (PubMed ID: 35096613)
1. FAM21C Promotes Hepatocellular Carcinoma Invasion and Metastasis by Driving Actin Cytoskeleton Remodeling
Lu Y; Huang D; Wang B; Zheng B; Liu J; Song J; Zheng S
Front Oncol; 2021; 11():809195. PubMed ID: 35096613
[TBL] [Abstract][Full Text] [Related]
2. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
Huang D; Cao L; Zheng S
J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia induces actin cytoskeleton remodeling by regulating the binding of CAPZA1 to F-actin via PIP2 to drive EMT in hepatocellular carcinoma.
Huang D; Cao L; Xiao L; Song JX; Zhang YJ; Zheng P; Zheng SG
Cancer Lett; 2019 Apr; 448():117-127. PubMed ID: 30742939
[TBL] [Abstract][Full Text] [Related]
4. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():634167. PubMed ID: 33777788
[TBL] [Abstract][Full Text] [Related]
5. Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice.
Peng JM; Bera R; Chiou CY; Yu MC; Chen TC; Chen CW; Wang TR; Chiang WL; Chai SP; Wei Y; Wang H; Hung MC; Hsieh SY
Hepatology; 2018 Jun; 67(6):2226-2243. PubMed ID: 29171033
[TBL] [Abstract][Full Text] [Related]
6. MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition.
Lin J; He Y; Chen L; Chen X; Zang S; Lin W
Clin Exp Med; 2018 Nov; 18(4):523-533. PubMed ID: 29855744
[TBL] [Abstract][Full Text] [Related]
7. Ras Homolog Family Member F, Filopodia Associated Promotes Hepatocellular Carcinoma Metastasis by Altering the Metabolic Status of Cancer Cells Through RAB3D.
Li S; Liu Y; Bai Y; Chen M; Cheng D; Wu M; Xia J
Hepatology; 2021 Jun; 73(6):2361-2379. PubMed ID: 33205519
[TBL] [Abstract][Full Text] [Related]
8. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting
Tsugawa H; Mori H; Matsuzaki J; Sato A; Saito Y; Imoto M; Suematsu M; Suzuki H
Autophagy; 2019 Feb; 15(2):242-258. PubMed ID: 30176157
[No Abstract] [Full Text] [Related]
9. Prognostic value of CAPZA1 overexpression in gastric cancer.
Lee YJ; Jeong SH; Hong SC; Cho BI; Ha WS; Park ST; Choi SK; Jung EJ; Ju YT; Jeong CY; Kim JW; Lee CW; Yoo J; Ko GH
Int J Oncol; 2013 May; 42(5):1569-77. PubMed ID: 23545944
[TBL] [Abstract][Full Text] [Related]
10. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
13. NcRNA-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma.
Qin T; Xiang W; Mao Y; Zhai H; Yang Z; Zhang H
Front Oncol; 2022; 12():1025192. PubMed ID: 36686785
[TBL] [Abstract][Full Text] [Related]
14. LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1.
Ji W; Peng Z; Sun B; Chen L; Zhang Q; Guo M; Su C
Front Oncol; 2021; 11():678714. PubMed ID: 34178664
[TBL] [Abstract][Full Text] [Related]
15. Nujiangexanthone A Inhibits Hepatocellular Carcinoma Metastasis via Down Regulation of Cofilin 1.
Zhang L; Chai Z; Kong S; Feng J; Wu M; Tan J; Yuan M; Chen G; Li Z; Zhou H; Cheng S; Xu H
Front Cell Dev Biol; 2021; 9():644716. PubMed ID: 33791303
[TBL] [Abstract][Full Text] [Related]
16. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression.
Wen Z; Lian L; Ding H; Hu Y; Xiao Z; Xiong K; Yang Q
RNA Biol; 2020 Mar; 17(3):381-394. PubMed ID: 31868085
[TBL] [Abstract][Full Text] [Related]
18. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.
Guo C; Zhao D; Zhang Q; Liu S; Sun MZ
Sci Rep; 2018 Feb; 8(1):2375. PubMed ID: 29403024
[TBL] [Abstract][Full Text] [Related]
19. PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process.
Gao Z; Zhong M; Ye Z; Wu Z; Xiong Y; Ma J; Chen H; Zhu Y; Yang Y; Zhao Y; Zhang Z
J Cancer; 2022; 13(1):153-161. PubMed ID: 34976179
[No Abstract] [Full Text] [Related]
20. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
